African Collaborative Center for Microbiome and Genomics Research (ACCME)


Principal Investigator:

Scientific Description:

The African Collaborative Center for Microbiome and Genomics Research (ACCME) leverages advanced research methods, technologies and international partnerships to engage African scientists and institutions led by the Institute of Human Virology, Nigeria (IHVN) and the Center for Infectious Diseases Research, Zambia (CIDRZ) to build capacity, conduct training and implement integrative epidemiology research initially focused on the associations between high risk HPV infection, vaginal microenvironment, HPV genomics, germline and somatic mutations in the etiology of cervical cancer.

This program serves as a paradigm for Translational Research in Biomarker Discovery that addresses high impact public health challenges that affects women’s health in Africa and the rest of the world. The technology and capacity developed through this initiative will be extended to other diseases in future.

Updated Aims:
Project 1-Epidemiology and Biomarker Discovery of Persistent high risk HPV (hrHPV) infection and Cervical Cancer in African women at risk of cervical cancer (EPIC-Biomarker Study)

1.1          Specific aim 1: Determine the epidemiology and molecular genetic patterns of persistent hrHPV infection in a cohort of women in East (Zambian) and West (Nigerian) African women.
1.2          Specific aim 2: Evaluate the epidemiological determinants and role of epigenetic changes in hrHPV and cervical cells as biomarkers of persistent hrHPV infection and CIN2+.

Project 2-Discovery of Biomarkers of the association between the Vaginal Microenvironment and persistent high risk HPV (hrHPV) infection (The Maverick Study)
1.1          Specific aim 1: Evaluate the epidemiological determinants of pattern of cervical cytokines in East (Zambian) and West African women using culture independent molecular techniques and their association with persistent hrHPV infection
1.2          Specific aim 2: Conduct comparative analysis of the classes and stability of the vaginal microbiota of East and West African women using culture independent molecular techniques and their association with persistent hrHPV infection.

Project 3– Gene Discovery of Risks of persistent hrHPV infection (hrHPV), cervical cytokines, patterns and stability of vaginal microbiome and CIN2+ (The Gene-Disc Project)
1.1.         Specific aim 1: Conduct genome-wide association studies (GWAS) to identify the genetic variants associated with risk of (a) persistent hrHPV infection and CIN2+ in East (Zambian) and West (Nigerian) African women.
1.2.         Specific aim 2: Evaluate germline risk factors identified in aim 1; from published studies in other populations and from the cervical cancer genome atlas for association with (a) persistent hrHPV infection, (b) patterns of cervical cytokines secretions, (c) pattern and stability of vaginal microbiome and (d) CIN2+ in East (Zambian) and West (Nigerian) African women.

IEARDA
1.1.         Specific aim 1: Provide effective administrative management and careful oversight of the ACCME award
1.2.         Specific aim 2: Foster research activities at collaborating institutions and provide training in grants and manuscript writing, and research administration that empowers ACCME scientists to be competitive and ensure grant funded sustainability of ACCME

Training, Capacity Development and Technology Transfer Project (TRACAD project)
1.1.         Specific Aim 1: Provide post-doctoral training to 8 highly qualified African candidates through a rigorous and competitive pan-African candidate selection process
1.2.         Specific Aim 2: Conduct short and medium term, local and international sandwich trainings in research methods, epidemiology, bioinformatics, biostatistics and data management, laboratory methods, social and behavioral research for African scientists at the IHVN, Abuja, Nigeria; CIDRZ, Lusaka, Zambia; and the AUST, Abuja, Nigeria.

April 4, 2018

African Collaborative Center for Microbiome and Genomics Research (ACCME)

The African Collaborative Center for Microbiome and Genomics Research (ACCME) leverages advanced research methods, technologies and international partnerships to engage African scientists
April 4, 2018

Prof. Clement Adebamowo

Institute of Human Virology Abuja, Nigeria
April 4, 2018

Burden, spectrum and etiology of type 2 diabetes in sub-Saharan Africa

Our primary aim is to assess the burden and aetiological characteristics of T2D in adults in SSA using large scale population based approaches. To achieve this, we aim to develop a large scale epidemiological and genomic research resource comprising up to 12,000 cases of T2D and a population based cross-sectional study of up to 12,000 participants drawn from diverse sampling frames across SSA. Scientific objectives:
April 4, 2018

Prof. Ayesha Motala

Professor and Head Department of Diabetes and Endocrinology School of Clinical Medicine
April 4, 2018

TrypanoGEN: An integrated approach to the identification of genetic determinants of susceptibility to trypanosomiasis

The over-arching aim of this network is to improve the health of people living in some of the poorest countries in the world that carry a disproportionate burden of infectious diseases. Despite their importance, the study of many tropical diseases has lagged behind that of diseases of developed countries.
April 4, 2018

Dr. Enock Matovu

Makerere University, Kampala, Uganda
April 4, 2018

The RHDGen Network: Genetics of rheumatic heart disease and molecular epidemiology of Streptococcus pyogenes pharyngitis

Rheumatic heart disease (RHD) results from a harmful response of the immune system to a bacterium called Streptococcus pyogenes or Group A Streptococcus (GAS). Although the development of RHD can be prevented by the treatment of GAS infection with penicillin, this has not been successful in
April 4, 2018

Dr. Bongani Mayosi

Dr. Bongani Mayosi Chair, NCD Working Group Bongani M. Mayosi, […]
April 4, 2018

Dr. Charmaine D. M. Royal

Dr. Charmaine Royal is an associate research professor at the Institute for Genome Sciences & Policy and the Department of African and African American Studies at Duke University